# FDA Inspection 869423 - Deliz Pharmaceutical Corp. - March 06, 2014

Source: https://www.keypedia.com/records/fda_inspections/deliz-pharmaceutical-corp/a4b1dd9a-73fd-4665-8ffe-f28934240565
Source feed: FDA_Inspections

> FDA Inspection 869423 for Deliz Pharmaceutical Corp. on March 06, 2014. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 869423
- Company Name: Deliz Pharmaceutical Corp.
- Inspection Date: 2014-03-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 993198 - 2016-11-09](https://www.keypedia.com/records/fda_inspections/deliz-pharmaceutical-corp/1482d2bc-f805-4d44-924b-09854ed201a3)
- [FDA Inspection 869423 - 2014-03-06](https://www.keypedia.com/records/fda_inspections/deliz-pharmaceutical-corp/af78b96d-3800-4124-acae-b9dc46afe526)
- [FDA Inspection 719154 - 2011-04-11](https://www.keypedia.com/records/fda_inspections/deliz-pharmaceutical-corp/75a22a36-763b-4f83-846c-04619bb87116)
- [FDA Inspection 719154 - 2011-04-11](https://www.keypedia.com/records/fda_inspections/deliz-pharmaceutical-corp/584d5dba-c75d-446e-83fc-90313c9daf46)

Company: https://www.keypedia.com/companies/deliz-pharmaceutical-corp/c99180d8-036a-453b-ad66-fe074d49c95f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c